Related Experiment Videos

Amipaque myelography. The side effects compared with Dimer X

Neuroradiology
|August 29, 1975
PubMed

Insights

Amipaque (metrizamide) is a safe and effective contrast agent for lumbar and thoracocervical myelography, showing minimal side effects compared to Dimer X. A novel C1-C2 lateral puncture technique proved safe for cervical imaging.

Area of Science:

  • Radiology
  • Neuroradiology
  • Diagnostic Imaging

Background:

  • Lumbar myelography is a common diagnostic procedure.
  • Dimer X and Amipaque (metrizamide) are contrast agents used in myelography.
  • Evaluating the safety and efficacy of contrast agents is crucial for patient outcomes.

Purpose of the Study:

  • To compare the efficacy and side effect profiles of Dimer X and Amipaque (metrizamide) for lumbar myelography.
  • To assess the utility and patient comfort of Amipaque for thoracocervical myelography.
  • To evaluate a new lateral puncture technique for cervical myelography.

Main Methods:

  • Comparative study of Dimer X and Amipaque (metrizamide) in lumbar myelography.
  • Application of Amipaque for thoracocervical myelography.
  • Introduction and evaluation of a lateral C1-C2 puncture technique under fluoroscopic guidance for cervical imaging.

Main Results:

  • Amipaque demonstrated a slightly higher frequency of minor, non-significant side effects compared to Dimer X in lumbar myelography.
  • Amipaque yielded excellent results for thoracocervical myelography with comparable discomfort to lumbar procedures.
  • The novel lateral C1-C2 puncture technique was successfully employed in over 75 examinations without observed arachnoid changes.

Conclusions:

  • Amipaque is a suitable and well-tolerated contrast agent for both lumbar and thoracocervical myelography.
  • The new lateral puncture technique offers a safe and effective approach for cervical myelography.
  • These findings support the expanded use of Amipaque and the novel puncture technique in neuroradiological imaging.

Related Concept Videos